Welcome Prof. Dr. Ondrej Slaby to the Editorial Board of Non-Coding RNA

We are pleased to announce that Prof. Dr. Ondrej Slaby from the Central European Institute of Technology (CEITEC) and Masaryk Memorial Cancer Institute (Brno, Czech Republic) has joined the Editorial Board of the journal Non-Coding RNA (ISSN 2311-553X). Dr. Slaby is an internationally recognized leader in non-coding RNA research and oncology, and we firmly believe that his expertise will be a worthwhile addition to our esteemed group of experts.

Prof. Dr. Ondrej Slaby graduated and completed his Ph.D. at Masaryk University (Brno, Czech Republic) in medical biochemistry.

Currently, Prof. Dr. Slaby is leading his research group at the Central European Institute of Technology (CEITEC). His research focuses on the study of the diagnostic and therapeutic potential of ncRNAs (e.g., microRNAs and lncRNAs) in oncology. His investigations comprise several cancers, such as colorectal cancer, renal cell carcinoma, and glioblastoma. To date, Prof. Dr. Slaby has discovered several new oncogenic and tumor-suppressive non-coding RNAs in solid cancer (e.g., miR-215 or long non-coding RNA ZFAS1). A combined microRNA/piRNA signature identified by his group is now under development as a new certified diagnostic in colorectal cancer.

Prof. Dr. Slaby believes in a bright future and strong translational potential of non-coding RNAs for the diagnosis and therapy of cancer.